Human papillomavirus vaccination at the first opportunity: An overview.
Human papillomavirus vaccination at the first opportunity: An overview.
复制标题
DOI:
10.1080/21645515.2023.2213603
复制
发表时间:
2023-12-31
影响因子:
4.8
通讯作者:
中科院分区:
文献类型:
--
作者:
The Advisory Committee on Immunization Practices (ACIP) has recommended human papillomavirus (HPV) vaccination for adolescents in the United States since 2006. Though recommended at a similar time to the routine recommendations for adolescent tetanus, diphtheria, and acellular pertussis vaccination (Tdap) and quadrivalent meningococcal vaccination (MCV4), HPV vaccine uptake has consistently lagged behind these other adolescent vaccines. The ACIP recommends HPV vaccination at 11–12 y, with vaccination starting at 9 y of age included as an option that is routinely encouraged by the American Academy of Pediatrics and American Cancer Society. To support efforts to increase HPV vaccination at the first opportunity, this commentary summarizes the current HPV vaccination recommendations and available evidence regarding HPV vaccination starting at 9 y – including recent studies and trials documenting the effectiveness of HPV vaccination at 9 in supporting vaccine series completion, while providing future directions for research and implementation to improve HPV vaccination.
登录
查看更多内容
影响因子:
4.8
作者:
通讯作者:
--
影响因子:
3.7
作者:
Casey, Sharon M.;Jansen, Emily;Perkins, Rebecca B.
通讯作者:
Perkins, Rebecca B.
影响因子:
4.8
作者:
Kasting ML;Shapiro GK;Rosberger Z;Kahn JA;Zimet GD
通讯作者:
Zimet GD
影响因子:
5.5
作者:
Fenton ATHR;Orefice C;Eun TJ;Biancarelli D;Hanchate A;Drainoni ML;Perkins RB
通讯作者:
Perkins RB
影响因子:
8
作者:
Bocchini, Joseph A., Jr.;Baltimore, Robert S.;Rubin, Lorry G.
通讯作者:
Rubin, Lorry G.